NBY NOVABAY PHARMACEUTICALS INC Disposals and divestitures 8-K Filing 2024 - Asset Sale Agreement NovaBay Pharmaceuticals is selling its Avenova eyecare products and related assets to PRN for $9.5 million, and plans to dissolve the company after the sale is completed, subject to stockholder approval.Get access to all SEC 8-K filings of the NOVABAY PHARMACEUTICALS INC